Soru

Zorluk: Çok zorEndocrinology and Metabolism

An electrocardiogram previously documented ventricular tachycardia in a 6868-year-old man. He now visits the physician complaining of severe palpitations, unintended weight loss, and profound fatigue persisting for the last 33 weeks. His medical history includes ischemic cardiomyopathy and placement on a rhythm-control medication approximately 1414 months ago. Current medications include lisinopril, carvedilol, and aspirin. The patient's temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 142/86142/86 mm Hg, and pulse is 115115/min and irregularly irregular. Physical examination demonstrates brisk deep tendon reflexes and a prominent bilateral hand tremor. Palpation of the neck reveals a diffusely firm, slightly enlarged thyroid gland with no distinct nodules.

Laboratory studies reveal:
Thyroid-stimulating hormone (TSH): <0.01 μU/mL<0.01 \ \mu\text{U/mL}
Free thyroxine (T4): 4.1 ng/dL4.1 \text{ ng/dL}
Total triiodothyronine (T3): 195 ng/dL195 \text{ ng/dL}

A 2424-hour radioactive iodine uptake scan demonstrates 1%1\% uptake. Subsequent color Doppler ultrasonography of the thyroid shows a diffusely enlarged gland with markedly diminished internal vascularity. Which of the following is the most appropriate next step in the management of this patient's current condition?

  1. Initiation of oral prednisoneCevap
  2. B
    Initiation of oral methimazole
  3. C
    Administration of a saturated solution of potassium iodide
  4. D
    Referral for radioactive iodine ablation
  5. E
    Discontinuation of the rhythm-control medication and observation

Cevap

Initiation of oral prednisone
The correct answer is the initiation of oral prednisone. This patient has amiodarone-induced thyrotoxicosis (AIT). Amiodarone is an iodine-rich antiarrhythmic drug that can cause thyrotoxicosis via two distinct mechanisms. Type 1 AIT typically occurs in patients with underlying thyroid pathology (e.g., multinodular goiter) and involves iodine-induced overproduction of thyroid hormone; Doppler ultrasonography shows increased vascularity, and the treatment of choice is thionamides (e.g., methimazole). In contrast, Type 2 AIT is a destructive thyroiditis where preformed thyroid hormone is released into the circulation, typically occurring in normal thyroid glands. Color Doppler ultrasonography demonstrates markedly decreased vascularity, as seen in this patient. Because the mechanism is inflammatory destruction rather than hormone synthesis, thionamides are ineffective. The first-line treatment for Type 2 AIT is glucocorticoids (e.g., prednisone). The 24-hour radioactive iodine uptake is uniformly low in both types due to competitive inhibition by the massive iodine load from amiodarone, making it unhelpful for distinguishing between the two.

Adım Adım Çözüm

1
Identify the underlying cause of the patient's thyrotoxicosis based on the medical history.
The patient has a history of ventricular tachycardia treated with an unnamed rhythm-control drug, which is amiodarone. Amiodarone is known to cause thyroid dysfunction.
Amiodarone contains a massive iodine load and exerts direct toxic effects on thyroid follicular cells.
2
Differentiate between the subtypes of amiodarone-induced thyrotoxicosis using the provided diagnostic tests.
The color Doppler ultrasound shows markedly diminished internal vascularity, pointing definitively to a destructive thyroiditis (Type 2 AIT) rather than increased hormone synthesis (Type 1 AIT).
Radioactive iodine uptake is uniformly low (e.g., 1%) in both AIT types due to the intense iodine load from the drug, making color Doppler ultrasound the essential differentiating test.
3
Determine the appropriate pharmacotherapy for the identified subtype.
Glucocorticoids, such as oral prednisone, are selected to treat the destructive inflammatory process.
Because Type 2 AIT involves the release of preformed hormone via cellular destruction, hormone synthesis inhibitors like methimazole are ineffective.

Anahtar Kavram

Management of Type 2 Amiodarone-Induced Thyrotoxicosis (Destructive Thyroiditis)
Bu soruyu puanla